A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors

Sven De Vos, Andres Forero-Torres, Stephen M. Ansell, Brad Kahl, Bruce D. Cheson, Nancy L. Bartlett, Richard R. Furman, Jane N. Winter, Henry Kaplan, John Timmerman, Nancy C. Whiting, Jonathan G. Drachman, Ranjana Advani

Research output: Contribution to journal › Article › peer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors'. Together they form a unique fingerprint.

Medicine & Life Sciences